Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Dillon

Showing results (181-190 of 185) with videos related to

Pageof 19
Sort By:
You have reached the last page of results.This site can display upto 185 results.
Bone Marrow Transplantation|October 25, 2024
Measurable residual mutated IDH2 before allogeneic transplant for acute myeloid leukemiaGege Gui, Niveditha Ravindra, Pranay S Hegde, et al.
Bone Marrow Transplantation|November 25, 2025
Measurable residual mutated NPM1 before allogeneic transplant for acute myeloid leukemiaRasha W Al-Ali, Gege Gui, Niveditha Ravindra, et al.
Blood Advances|February 10, 2025
Randomized phase 2 study to assess the role of single-agent nivolumab to maintain remission in acute myeloid leukemiaAthalia R Pyzer, Laura W Dillon, Elad Sharon, et al.
The New England Journal of Medicine|October 27, 2020
Somatic Mutations in <i>UBA1</i> and Severe Adult-Onset Autoinflammatory DiseaseDavid B Beck, Marcela A Ferrada, Keith A Sikora, et al.
Medrxiv : the Preprint Server for Health Sciences|December 17, 2025
Genomics of Acute Myeloid Leukemia at Diagnosis and RemissionKai Yu, Laura W Dillon, Jesse M Tettero, et al.
Pageof 19

Showing results (181-190 of 185) with videos related to

Sort By:
Pageof 19
You have reached the last page of results.This site can display upto 185 results.
Bone Marrow Transplantation|October 25, 2024
Measurable residual mutated IDH2 before allogeneic transplant for acute myeloid leukemiaGege Gui, Niveditha Ravindra, Pranay S Hegde, et al.
Bone Marrow Transplantation|November 25, 2025
Measurable residual mutated NPM1 before allogeneic transplant for acute myeloid leukemiaRasha W Al-Ali, Gege Gui, Niveditha Ravindra, et al.
Blood Advances|February 10, 2025
Randomized phase 2 study to assess the role of single-agent nivolumab to maintain remission in acute myeloid leukemiaAthalia R Pyzer, Laura W Dillon, Elad Sharon, et al.
The New England Journal of Medicine|October 27, 2020
Somatic Mutations in <i>UBA1</i> and Severe Adult-Onset Autoinflammatory DiseaseDavid B Beck, Marcela A Ferrada, Keith A Sikora, et al.
Medrxiv : the Preprint Server for Health Sciences|December 17, 2025
Genomics of Acute Myeloid Leukemia at Diagnosis and RemissionKai Yu, Laura W Dillon, Jesse M Tettero, et al.
Pageof 19